Thiabendazole, Dexamethasone, Neomycin Sulfate
156 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
156
Total Reports
28
Deaths Reported
1790.0%
Death Rate
Active Ingredients
Thiabendazole, Dexamethasone, Neomycin Sulfate
Administration Routes
Auricular (Otic)TopicalUnknownOphthalmicOther
Species Affected
Cat 96
Dog 60
Most Affected Breeds
Domestic Shorthair 52
Domestic Longhair 9
Domestic Mediumhair 8
Retriever - Labrador 8
Cat (other) 8
Shih Tzu 6
Cat (unknown) 4
Terrier - Yorkshire 3
Persian 3
Maltese 3
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 42
Other abnormal test result NOS 20
Vomiting 19
Anorexia 15
Death 15
Decreased appetite 14
Seizure NOS 13
Diarrhoea 12
Death by euthanasia 11
Weight loss 11
Elevated alanine aminotransferase (ALT) 11
Fever 10
Outcome Breakdown
Ongoing
96 (61.5%)
Outcome Unknown
21 (13.5%)
Died
17 (10.9%)
Euthanized
11 (7.1%)
Recovered/Normal
11 (7.1%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.